Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy

SIMPLE SUMMARY: The prostate-specific membrane antigen (PSMA) protein present in most prostate cancer cells has emerged as a promising target for the imaging and treatment of prostate cancer. With the development of monoclonal antibodies (mAbs) against PSMA, cancer cells can be targeted effectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Abusalem, Mohammed, Martiniova, Lucia, Soebianto, Sarita, DePalatis, Louis, Ravizzini, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526399/
https://www.ncbi.nlm.nih.gov/pubmed/37760506
http://dx.doi.org/10.3390/cancers15184537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526399/
https://www.ncbi.nlm.nih.gov/pubmed/37760506
http://dx.doi.org/10.3390/cancers15184537

Ejemplares similares